VivoSim Labs, Inc. Operating Lease, Expense
VivoSim Labs, Inc. (VIVS) reported Operating Lease, Expense of $126.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-11-09
- VivoSim Labs, Inc. operating lease, expense for the quarter ending 2023-09-30 was $126.00K, a 2.33% decline year-over-year.
- VivoSim Labs, Inc. operating lease, expense for the quarter ending 2023-06-30 was $126.00K, a 2.33% decline year-over-year.
- VivoSim Labs, Inc. operating lease, expense for the quarter ending 2023-03-31 was $126.00K, a 2.33% decline year-over-year.
- VivoSim Labs, Inc. operating lease, expense for the quarter ending 2022-12-31 was $114.00K, a 165.12% increase year-over-year.
- VivoSim Labs, Inc. operating lease, expense for fiscal 2023 was $499.00K, a 190.12% increase from fiscal 2022.
- VivoSim Labs, Inc. operating lease, expense for fiscal 2022 was $172.00K.
- VivoSim Labs, Inc. operating lease, expense for fiscal 2021 was $0.00.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $126.00K 10-Q · filed 2023-11-09 | $252.00K 10-Q · filed 2023-11-09 | $378.00K derived: sum of 3 quarters · filed 2023-11-09 | $492.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-06-30 | $126.00K 10-Q · filed 2023-08-10 | $252.00K derived: sum of 2 quarters · filed 2023-08-10 | $366.00K derived: sum of 3 quarters · filed 2023-08-10 | $495.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-03-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $240.00K derived: sum of 2 quarters · filed 2023-07-14 | $369.00K derived: sum of 3 quarters · filed 2023-11-09 | $499.00K 10-K · filed 2023-07-14 | |||
| 2022-12-31 | $114.00K 10-Q · filed 2023-02-09 | $243.00K derived: sum of 2 quarters · filed 2023-11-09 | $373.00K 10-Q · filed 2023-02-09 | $501.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-09-30 | $129.00K 10-Q · filed 2023-11-09 | $129.00M 10-Q · filed 2022-11-10 | $258.00K 10-Q · filed 2023-11-09 | $258.00M 10-Q · filed 2022-11-10 | $387.00K derived: sum of 3 quarters · filed 2023-11-09 | $430.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $129.00K 10-Q · filed 2023-08-10 | $129.00M 10-Q · filed 2022-08-11 | $258.00K derived: sum of 2 quarters · filed 2023-08-10 | $301.00K derived: sum of 3 quarters · filed 2023-08-10 | $301.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $172.00K derived: sum of 2 quarters · filed 2023-07-14 | $172.00K derived: sum of 3 quarters · filed 2023-07-14 | $172.00K 10-K · filed 2023-07-14 | |||
| 2021-12-31 | $43.00K 10-Q · filed 2023-02-09 | $43.00M 10-Q · filed 2022-02-14 | $43.00K derived: sum of 2 quarters · filed 2023-02-09 | $43.00K 10-Q · filed 2023-02-09 | $43.00M 10-Q · filed 2022-02-14 | $43.00K derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 3 quarters · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | $0.00 derived: sum of 2 quarters · filed 2022-06-10 | $0.00 10-K · filed 2022-06-10 | ||||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |